Alleviation of the hypoxic environment downregulates hypoxic markers in cells, including HIF-1α, which promotes multidrug resistance (MDR) and reoxygenates the tumor environment to promote therapeutic efficacy. The gene discussed is HIF1A; the disease is neoplasm.